Thousands of people in Oklahoma may have been infected with HIV and hepatitis after health officials discovered evidence that a dentist in Tulsa was not properly sterilizing the tools and equipment he used on his patients, despite knowing that several of them carried the viruses.
A drug in an early trial promises good results in treating hepatitis C.
The machine could go to market as early as 2014.
Researchers report that melittin, found in bee venom, can attack the membranes of the HIV virus.
Gilead Science Inc's reported promising results from its newest hepatitis C drug, sofosbuvir. The cure rates for patients with genotype two and three were higher on sofosbuvir than regular hepatitis C medicine. The company plans on increasing its numbers before introducing the drug.
Local authorities in Northern China announced yesterday that 95 citizens had been hospitalized because of suspected hepatitis C that they reportedly obtained from a private clinic.